ARCHIVES

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Reagan Signs Skins Cancer Resolution

March 29, 1985

Barnett Kramer Retires From NIH

January 7, 2011

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Panel Says NIH Must Devise Means For Early Release Of Trials Data

January 25, 1991

From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas

January 27, 2012

Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed

December 12, 1975